| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |